THE INTERNATIONAL CANCER GENOME CONSORTIUM authorized its 1,000th user, giving them access to the Consortium’s Controlled Access datasets. ICGC datasets that catalogue tumor-specific mutations are unrestricted and freely available to the scientific community. However, the consortium developed an authorization process to distribute clinical and inherited genetic data associated with unique individuals in order to minimize...
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
